US Patent Issued to Seelos Therapeutics on March 4 for "Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose" (Israeli Inventor)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,733, issued on March 4, was assigned to Seelos Therapeutics Inc. (New York).

"Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose" was invented by Dalia Megiddo (Nataf, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose."

The patent was filed on April 5, 2023, under Application No....